Long-Term Effects of COVID-19 on Children: A Review

Introduction

A recent review has assessed the latest research to determine the long-term impact of COVID-19 symptoms in children. As the COVID-19 pandemic continues to influence daily life globally, ongoing research on the SARS-CoV-2 virus aims to reduce the disease’s incidence and prevalence. Despite substantial advancements, many aspects of COVID-19 pathology remain unclear, with emerging studies indicating that the virus may cause persistent symptoms after recovery, such as shortness of breath, cough, and altered senses of smell or taste.

COVID-19 Risk in Children

Generally, children are not categorized as high-risk for severe illness due to COVID-19. In fact, they exhibit the lowest case mortality rates compared to other age groups. However, children can still contract and transmit the virus, and the long-term health implications of COVID-19 in this demographic are not yet fully understood. Currently, the two mRNA vaccines authorized for use in the United States are approved only for individuals aged twelve and older.

Research Overview

Researchers from the University of Fribourg in Switzerland sought to explore whether COVID-19 could have lasting effects on children, specifically looking for persistent symptoms, also referred to as post-COVID syndrome or PASC. Their analysis reviewed 14 relevant studies involving over 19,000 children and adolescents from high-income countries.

Findings on Long-Term Symptoms

The studies examined the prevalence of long-term COVID-19 symptoms that persisted four to twelve weeks following the initial SARS-CoV-2 infection. Results varied significantly, with the percentage of children experiencing long-term symptoms ranging from 4% to 66%. Commonly reported symptoms included headaches, abdominal pain, nasal congestion, cough, chest tightness, loss of appetite and smell, rashes, and difficulties with sleep and concentration.

Conclusion

The findings suggest that long-term symptoms of COVID-19 may be relatively common among children. However, the significant variance in study outcomes complicates the interpretation of these results. Additional research is essential to determine the long-term effects of COVID-19 on children and to develop effective treatment and management strategies for any potential lasting impacts.

References

1. Nalbandian, A., Seghal, K., Wan, E.Y., et al. (2021, March 22). Post-acute COVID-19 syndrome. Nature Medicine, 27: 601-615. doi: 10.1038/s41591-021-01283-z
2. Centers for Disease Control and Prevention (2021, August 20). COVID-19: Medical Conditions. The U.S. Department of Health and Human Services. Accessed September 23, 2021, from https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
3. Koh, H.K., Geller, A.C., VanderWeele, T.J. (2020, December 17). Deaths from COVID-19. JAMA, 325(2): 133-134. doi: 10.1001/jama.2020.25381
4. Children’s Hospital Association (2020, December 3). Children and COVID-19: State Data Report. The American Academy of Pediatrics. Accessed September 23, 2021, from https://downloads.aap.org/AAP/PDF/AAP%20and%20CHA%20-%20Children%20and%20COVID-19%20State%20Data%20Report%2012.3.20%20FINAL.pdf
5. Zimmermann, P., Pittet, L.F., Curtis, N. (2021, September 16). How Common is Long COVID in Children and Adolescents? The Pediatric Infectious Disease Journal. doi: 10.1097/INF.0000000000003328
6. Coronavirus disease (COVID-19). (2021, September 16). Approved COVID-19 Vaccines. Government of Canada. Accessed September 23, 2021, from https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines.html